Creatinine
EstablishedCreatinine is the standard kidney function marker, forming the basis of eGFR calculations and AKI diagnostic criteria.
Creatinine is the most basic and widely used kidney function blood test, though it's skewed by muscle mass — which is exactly why the cystatin C test discussed elsewhere in this set was developed as a fairer alternative for people with unusually high or low muscle mass.
Creatinine is a muscle metabolism byproduct filtered by the kidneys at a relatively constant rate, making it the most widely used marker of kidney filtration function, connecting directly to the Cystatin C entry elsewhere in this biomarker set.
Elevated creatinine indicates reduced kidney filtration (glomerular filtration rate), used both as a standalone marker and, more commonly, as the basis for calculated estimated GFR (eGFR) equations used to stage chronic kidney disease.
Measured via enzymatic or Jaffe colorimetric assay; results are affected by muscle mass (higher in muscular individuals, lower in frail or amputee patients regardless of true kidney function), which is precisely why cystatin C-based or combined equations, discussed earlier in this biomarker set, were developed to reduce this bias.
Serial creatinine is used to define acute kidney injury (per KDIGO criteria, a rise of ≥0.3 mg/dL within 48 hours or ≥1.5x baseline within 7 days) and to monitor chronic kidney disease progression, directly informing nephrology referral timing and dosing adjustments for renally-cleared medications.
Muscle-mass dependence is a well-known limitation, addressed by cystatin C-based equations discussed elsewhere in this set.
- General nephrology reference literature on serum creatinine in eGFR calculation and acute kidney injury diagnostic criteria (KDIGO).